NOTCH and Graft-Versus-Host Disease

Frontiers in Immunology
Mauro Di IanniFranca Falzetti

Abstract

In allogeneic hematopoietic stem cell transplantation, which is the major curative therapy for hematological malignancies, T cells play a key role in the development of graft-versus-host disease (GvHD). NOTCH pathway is a conserved signal transduction system that regulates T cell development and differentiation. The present review analyses the role of the NOTCH signaling as a new regulator of acute GvHD. NOTCH signaling could also represent a new therapeutic target for GvHD.

References

May 10, 1979·The New England Journal of Medicine·P L WeidenR Storb
Jun 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S YamagiwaD A Horwitz
Apr 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Massimo C FantiniMarkus F Neurath
Oct 26, 2005·Nature Immunology·Karsten KretschmerHarald von Boehmer
Dec 16, 2006·Nature Reviews. Immunology·Barbara A Osborne, Lisa M Minter
Feb 19, 2008·Experimental Hematology·Mauro Di IanniAntonio Tabilio
Sep 16, 2008·Best Practice & Research. Clinical Haematology·Katayoun Rezvani, A John Barrett
Jan 24, 2009·Seminars in Cell & Developmental Biology·Michael S Wolfe
Jan 24, 2009·Nature Reviews. Immunology·Derk AmsenRichard A Flavell
Jan 26, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Joseph Pidala, Claudio Anasetti
Feb 16, 2010·Immunity·Freddy RadtkeH Robson Macdonald
Jul 6, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel WolffHildegard Greinix
Apr 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John R WingardGérard Socié
Apr 26, 2011·Journal of Immunological Methods·Patrick J SchulerTheresa L Whiteside
Jul 14, 2011·PLoS Pathogens·Maria NikolovaYves Lévy
Mar 17, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hongmei LiWarren D Shlomchik
May 12, 2012·Nature Reviews. Immunology·Bruce R BlazarMehrdad Abedi
Jul 17, 2012·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Mauro Di IanniFranca Falzetti
Nov 20, 2012·European Journal of Immunology·Beatrice Del PapaMauro Di Ianni
Feb 27, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kazuhiro MochizukiYi Zhang
Mar 5, 2013·The Journal of Clinical Investigation·Ivy T TranIvan Maillard
May 3, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ashley R SandyIvan Maillard
Jun 5, 2013·Journal of Cell Science·Kazuya HoriSpyros Artavanis-Tsakonas
Jun 5, 2013·The Journal of Experimental Medicine·Justine E RoderickLisa M Minter
Dec 5, 2013·Frontiers in Immunology·Marta CaridadeRuy M Ribeiro
Dec 24, 2013·Blood·Massimo F MartelliAndrea Velardi
Oct 27, 2014·Nature Immunology·Ronald A BackerDerk Amsen
Oct 6, 2015·Nature Immunology·Louis-Marie CharbonnierTalal A Chatila
Nov 27, 2015·Science Translational Medicine·Scott N FurlanLeslie S Kean
Apr 30, 2016·Leukemia·B Del PapaM Di Ianni
Mar 16, 2017·Journal of Leukocyte Biology·Paola GrazioliAntonio Francesco Campese

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.